ViaCyte proposes stem cell implant to address type 1 diabetes

05/31/2011 | Los Angeles Times (tiered subscription model)

San Diego-based ViaCyte has proposed implanting a pouch filled with pancreatic cells under the skin to help reduce insulin dependence among patients with type 1 diabetes. The firm tested the procedure to treat diabetes in mice and hopes to initiate human trials in patients by 2013.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX